BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37268198)

  • 1. Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation.
    Qian X; Zhu L; Xu M; Liu H; Yu X; Shao Q; Qin J
    Chem Biol Interact; 2023 Sep; 382():110588. PubMed ID: 37268198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3.
    Wan Y; Cheng J; Gan D; He J; Chen A; Ma J; Li Y; Wang X; Ran J; Chen D; Li J
    Chem Biol Drug Des; 2024 Jun; 103(6):e14565. PubMed ID: 38862254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATF3 Regulates Osteogenic Function by Mediating Osteoblast Ferroptosis in Type 2 Diabetic Osteoporosis.
    Zhao Y; Du Y; Gao Y; Xu Z; Zhao D; Yang M
    Dis Markers; 2022; 2022():9872243. PubMed ID: 36340581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe
    Ni M; Zhou J; Zhu Z; Xu Q; Yin Z; Wang Y; Zheng Z; Zhao H
    Phytomedicine; 2023 Apr; 112():154701. PubMed ID: 36773431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 activated by AROS sensitizes glioma cells to ferroptosis via induction of NAD+ depletion-dependent activation of ATF3.
    Chen X; Wang Z; Li C; Zhang Z; Lu S; Wang X; Liang Q; Zhu X; Pan C; Wang Q; Ji Z; Wang Y; Piao M; Chi G; Ge P
    Redox Biol; 2024 Feb; 69():103030. PubMed ID: 38181705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
    Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
    J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
    Fu D; Wang C; Yu L; Yu R
    Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shikonin Could Be Used to Treat Tubal Pregnancy via Enhancing Ferroptosis Sensitivity.
    Lai Y; Zeng F; Chen Z; Feng M; Huang Y; Qiu P; Zeng L; Ke Y; Deng G; Gao J
    Drug Des Devel Ther; 2022; 16():2083-2099. PubMed ID: 35800255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shikonin inhibits the proliferation of human lens epithelial cells by inducing apoptosis through ROS and caspase-dependent pathway.
    Huang WR; Zhang Y; Tang X
    Molecules; 2014 Jun; 19(6):7785-97. PubMed ID: 24962386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway.
    Wang H; Wu C; Wan S; Zhang H; Zhou S; Liu G
    Toxicology; 2013 Jun; 308():104-12. PubMed ID: 23562787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
    Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
    Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.
    Pan T; Zhang F; Li F; Gao X; Li Z; Li X; Ren X
    Oncol Rep; 2020 Sep; 44(3):1049-1063. PubMed ID: 32705271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway.
    Li X; Fan XX; Jiang ZB; Loo WT; Yao XJ; Leung EL; Chow LW; Liu L
    Pharmacol Res; 2017 Jan; 115():45-55. PubMed ID: 27864022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saikosaponin A triggers cell ferroptosis in hepatocellular carcinoma by inducing endoplasmic reticulum stress-stimulated ATF3 expression.
    Lan T; Wang W; Zeng XX; Tong YH; Mao ZJ; Wang SW
    Biochem Biophys Res Commun; 2023 Sep; 674():10-18. PubMed ID: 37393639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway.
    Li B; Yuan Z; Jiang J; Rao Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30420490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal Transition in Cervical Cancer Cells.
    Tang Q; Liu L; Zhang H; Xiao J; Hann SS
    Drug Des Devel Ther; 2020; 14():577-589. PubMed ID: 32103900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin induces apoptosis and prosurvival autophagy in human melanoma A375 cells via ROS-mediated ER stress and p38 pathways.
    Liu Y; Kang X; Niu G; He S; Zhang T; Bai Y; Li Y; Hao H; Chen C; Shou Z; Li B
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):626-635. PubMed ID: 30873870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A natural anthraquinone derivative shikonin synergizes with AZD9291 against wtEGFR NSCLC cells through reactive oxygen species-mediated endoplasmic reticulum stress.
    Hu X; Zhang ZY; Wu LW; Zeng LH; Chen H; Zhu HJ; Zhang JK; Shao J; Zhang C; Li YL; Lin NM
    Phytomedicine; 2020 Mar; 68():153189. PubMed ID: 32070867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing ATF3 Might Delay TBHP-Induced Intervertebral Disc Degeneration by Repressing NPC Ferroptosis, Apoptosis, and ECM Degradation.
    Li Y; Pan D; Wang X; Huo Z; Wu X; Li J; Cao J; Xu H; Du L; Xu B
    Oxid Med Cell Longev; 2022; 2022():4235126. PubMed ID: 35480873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.